Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

Pulmonary hypertension (PH) is characterized by a progressive elevation of mean arterial pressure followed by right ventricular failure and death. Previous studies have indicated that numerous inhibitors of receptor tyrosine kinase signaling could be either beneficial or detrimental for the treatmen...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Mol Sci
Главные авторы: Veeroju, Swathi, Kojonazarov, Baktybek, Weiss, Astrid, Ghofrani, Hossein Ardeschir, Weissmann, Norbert, Grimminger, Friedrich, Seeger, Werner, Novoyatleva, Tatyana, Schermuly, Ralph Theo
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867319/
https://ncbi.nlm.nih.gov/pubmed/33540939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22031502
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы